Mabtas 500mg Injection

Mabtas 500mg Injection Specification

Origin
India

Dosage Form
Injection

Salt Composition
Rituximab

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store at cool temperature

Mabtas 500mg Injection Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
40 Pieces Per Week

Delivery Time
4 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India, South India

About Mabtas 500mg Injection

Mabtas 500mg Injection contains rituximab, a monoclonal antibody used to treat certain types of cancers and autoimmune diseases.

Inform your doctor if you have heart, liver issues, plan surgery or vaccination, or are taking infection treatments. Effective contraception is advised during treatment, and this medicine is not recommended during pregnancy or breastfeeding.

Brand Name: Mabtas

Composition: Rituximab

Mechanism of Action:

Rituximab targets the CD20 antigen on B-lymphocytes (B-cells), which are involved in both normal immune function and the development of certain cancers like non-Hodgkin's lymphoma and CLL. Upon binding to CD20, rituximab induces B-cell death through multiple pathways, including direct apoptosis (cell death), activation of the complement system, and recruitment of immune cells that kill the antibody-tagged B-cells.

Uses:

Non-Hodgkins Lymphoma

Chronic Lymphocytic Leukemia

Rheumatoid Arthritis

Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) Pemphigus Vulgaris

Side Effects:

Skin rash

Itching

Hives

Swelling of the face, lips, or tongue

Diarrhea

Edema